Plate Fixation Versus Intramedullary Nailing of 3 and 4 Part Proximal Humerus Fractures

August 14, 2023 updated by: Asbjorn Aroen, University Hospital, Akershus

Plate Fixation Versus Intramedullary Nailing of 3 and 4 Part Proximal Humerus Fractures. A RCT

The purpose of the project is to compare the management of 3 and 4 part proximal humerus fractures (PHF) with an angular stable plate (Philos) with that of an intramedullary nail (Multiloc) in light of complications, radiological, economical, functional and clinical outcome.

Study Overview

Status

Active, not recruiting

Detailed Description

Randomized controlled trial (RCT) from Akershus University Hospital in Norway. Randomization between two implants. The investigators will use deltopectoral or deltoid split as surgical access. All patients will have calcar screws and cuff sutures. When lack of bone for example after decompressing valgus compressed fractures, a bone-substitute might be used in the surgeons preference. Follow up in outpatient clinic at 6, 12, 52 and 104 weeks, but also a 5 year follow up is planned. Postoperative radiographs of both shoulders and CT of operated shoulder will be taken.

Study Type

Interventional

Enrollment (Actual)

79

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lørenskog, Norway, 1478
        • Akershus University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients > 18 years
  2. Severe displacement, defined as malposition of at least 45⁰ of angular deviation in valgus or 30⁰ in varus in true frontal projection, regardless of whether the fracture is impacted or not. Fractures with more than 50% displacement of the head against the surgical neck
  3. The greater or lesser tubercles must be fractured in a 3 or 4-part fracture. The degree of displacement is not critical for inclusion.

Exclusion Criteria:

Exclusion criteria:

  1. Fracture more than 3 weeks' old
  2. Caput humeri just a thin shell or split
  3. Ipsilateral damage that will influence the recovery and scoring systems
  4. Incapability to protect osteosynthesis, i.e. use of crutches because of injury to lower extremity.
  5. Pathological fracture
  6. Neurovascular injury
  7. Open fracture
  8. Noncompliance
  9. Congenital anomaly
  10. Ongoing infectious process around the incision site for plate osteosynthesis
  11. Systemic disease that may influence healing processes or scoring systems (RA/MS)
  12. Fracture dislocation
  13. Substance abuse
  14. Inability to read and understand Norwegian
  15. Patients not residing in our catchment area
  16. Patients with too small humerus diameter to use a nail
  17. Patient not able to commit and understand written consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Philos plate
Intervention is surgery with Philos plate
Intervention is surgery with Philos plate
Active Comparator: Multiloc nail
Intervention is surgery with Multiloc nail
Intervention is surgery with Multiloc nail

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Disabilities of the Arm, Shoulder and Hand (DASH) Score (questionnaire) Disability of the arm, shoulder and arm score (DASH score)
Time Frame: 5 years
Quick Dash (questionnaire) the first 6 weeks after surgery, then DASH score (questionnaire for patients to fill out) in follow ups
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Constant score (questionnaire)
Time Frame: 5years
A questionnaire for the doctor or the physiotherapist to fill out, including registration of: Pain, Power, Range of motion and ADL (x/100, where 100 is best score)
5years
Radiological complications
Time Frame: 5 years
Plate cutout, Nail migration, screw cutout, Reduction of Head shaft angle (HSA)/ Varus subsidence,
5 years
Complications
Time Frame: 5 years
Infection, Avascular necrosis, thrombosis, nerve compression or damage, Pseudoarthrosis
5 years
Health economy
Time Frame: 5 years
Registration of visits to doctor, physiotherapist, sick leave, re-operations
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Asbjorn AAroen, PhD MD, Akershus University Hospital, orthopedic unit

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2016

Primary Completion (Estimated)

October 24, 2023

Study Completion (Estimated)

October 25, 2025

Study Registration Dates

First Submitted

October 17, 2016

First Submitted That Met QC Criteria

October 23, 2016

First Posted (Estimated)

October 25, 2016

Study Record Updates

Last Update Posted (Actual)

August 15, 2023

Last Update Submitted That Met QC Criteria

August 14, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified individual participant data for all primary and secondary outcome measures will be made available within 6 months of study completion

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Fractures

Clinical Trials on Philos plate

3
Subscribe